Husky Technologies™ plays a significant role in medical injection molding, combining precision tooling, integrated systems, and data-driven service into a cohesive platform. Its ICHOR™ Integrated Medical Injection System, built on Schöttli molds and supported by the Advantage+Elite™ service layer, has advanced medical manufacturing and shown it can be deployed effectively across multiple regions and regulatory environments. This performance earned Husky the Innovation and Business Expansion awards at the 2025 Medical Device Network Excellence Awards.
Husky won the Innovation award in the Integrated Systems category for consolidating molds, machines, controls, and service into a single engineered medical injection system that improves predictability and reduces variability. It received the Business Expansion award for Multi Region Rollout for successfully scaling this integrated model across multiple geographies, enabling consistent deployments in both mature and emerging medical manufacturing markets.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Integrated medical injection systems transforming validation and performance
Husky’s Innovation award centers on its success in turning a traditionally fragmented molding cell into a single, engineered medical platform. Historically, manufacturers sourced machines, molds, hot runners, auxiliaries, and software from multiple vendors and then stitched them together. Each interface added complexity, lengthened validation, and blurred accountability when issues arose.
ICHOR™ platform addresses this by unifying the entire system—Schöttli high-precision molds, Husky injection equipment, hot runners, auxiliaries, and controls—under one architecture with a unified HMI. Built on a PET-derived platform adapted for regulated environments, it brings the familiarity of high-volume packaging systems into a medical context without compromising traceability or compliance. This coherence reduces process variability, shortens the path from installation to validated state, and enables customers to reach stable, high-quality output more quickly.
Critically, Husky has extended its mold and process innovation into demanding categories such as pen/auto-injectors, syringes, blood collection tubes, and femcare components. The system supports high-cavity, complex parts at high throughput while maintaining dimensional accuracy and surface quality. This combination of precision and volume is central for medical consumables, where unit margins are tight but quality requirements are uncompromising.
The integration is reinforced by Advantage+Elite™, which embeds predictive service into the product lifecycle. With 24/7 remote monitoring and analytics, Husky can detect performance deterioration before it affects output, schedule interventions proactively, and support customers in optimizing OEE. This shifts uptime from a reactive maintenance outcome to something designed and managed as part of the system. Since its introduction, the widespread adoption of Advantage+Elite™ has demonstrated measurable improvements in efficiency, reliability, and part quality, turning the ICHOR™ platform into a technical and financial asset rather than a piece of isolated equipment.
Finally, Husky links this integration to clear business outcomes. Customers report reduced scrap, more stable cycles, extended mold life, and faster time-to-market for new applications. By concentrating accountability and control in one integrated platform, Husky has provided a direct, demonstrable connection between system design and P&L performance—an essential factor behind its recognition in the Integrated Systems subcategory.
Multi-region rollout enabling vertical integration and global capacity
Husky has not confined ICHOR™ platform and its related offerings to a few flagship sites; it has turned them into a repeatable model for multi-region deployment. This is evident in the way the company has balanced reshoring in established markets with first-of-kind installations in high-growth regions.
In mature economies such as the United States and France, Husky’s integrated approach has supported onshoring and capacity re-establishment. Deployments at manufacturers like Nephron Pharmaceuticals demonstrate how a complete system can underpin large-scale local production of critical medical consumables, improving supply chain resilience and reducing import dependence. In France, Husky’s return after a decade—on the strength of orders for full medical systems rather than standalone tooling—illustrates how its integrated proposition has been compelling enough to re-establish its presence in a mature, highly competitive market.
In growth regions, Husky has used the same integrated playbook to help customers transition from buyers to producers. In India, Kriya Medical Technologies and CML Biotech have deployed ICHOR™ systems with Schöttli molds and Advantage+Elite™ support to establish high-volume, compliant blood collection tube production. Cycle times below 5.5 seconds and annual capacities reaching hundreds of millions of tubes position these firms as cost-competitive, quality-assured suppliers to both domestic and export markets. Husky’s involvement has extended from defining the injection solution and resin selection to training and ongoing optimization, effectively enabling vertical integration rather than just delivering equipment.
A similar pattern is evident in Turkey, where SEM Plastik—as one of Turkey’s pioneers in sustainable packaging and now advanced medical manufacturing—has strategically expanded into the production of high-precision vacuum blood collection tubes, serving healthcare systems across Turkey and neighboring regions. By adopting Husky’s integrated system, the manufacturer achieved faster market entry, higher efficiency, and robust compliance with international standards. SEM’s partnership with Husky demonstrates how integrated system solutions enable local manufacturers to achieve world-class standards in medical molding.
Underpinning these projects are Husky’s Medical Tooling Centers of Excellence in Switzerland and California, which standardize mold design, process know-how, and validation methodologies. This concentration of expertise allows Husky to replicate high-performance solutions across geographies with consistent outcomes, rather than treating each installation as a one-off engineering exercise.
The cumulative effect is a global installed base that validates both the technology and the rollout model. Multi-country adoption, supported by extensive industry coverage, reduces perceived risk for new buyers and signals strong market pull. At the commercial level, Husky has paired capital equipment sales with long-term Advantage+Elite™ contracts, strengthening lifetime value and customer stickiness across regions.
“We are proud and honored to be awarded. This recognition reflects the collective expertise, depth of knowledge, and dedication of Husky’s team members globally. The 2025 Medical Device Network Excellence Awards acknowledges how our advanced technologies and comprehensive support enable medical device producers to achieve precision, reliability, and efficiency in applications ranging from pre-filled syringes, auto-injectors, pen-injectors to blood collection tubes, reaction cups, pipette tips, petri dishes, and more.” said Thomas Bontempi, Husky’s General Manager, Medical Business.
Company Profile
Since 1953, Husky Technologies™ has been pioneering technologies that enable the delivery of essential needs to the global community with industry-leading expertise and service. A global leader, Husky is powered by teams of exceptional people in more than 40 locations with valued customers who operate in over 140 countries. By focusing on sustainably sourced feedstocks, material reuse and the exclusive use of medical-grade polymers, Husky continues to be committed to enabling the circular economy now and into the future.
For more information, contact:
Media Relations
Husky Injection Molding Systems
Links
Website: www.husky.co
WeChat: https://www.husky.co/en/wechat/
